FOURNEL ADVISORY ADVISED ATHENA PHARMACEUTIQUES ON THE ARRANGEMENT OF ACQUISITION REFINANCING PROVIDED BY LA BANQUE POSTALE AND BNP PARIBAS
ATHENA PHARMACEUTIQUES develops and manufactures high value-added pharmaceutical products for mature and emerging markets. The group benefits from an integrated platform spanning the full value chain, from R&D to commercialization, through its industrial sites in France and India, as well as its research centers.
This refinancing transaction enables ATHENA PHARMACEUTIQUES to optimize its capital structure following a recent strategic acquisition, while strengthening its financial resources to pursue its growth strategy and international expansion.
By advising ATHENA PHARMACEUTIQUES on both external growth and financing matters, FOURNEL ADVISORY demonstrates its ability to deliver integrated strategic advisory services to leading healthcare companies.